BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18052061)

  • 1. Structural and initial biological analysis of synthetic arylomycin A2.
    Roberts TC; Smith PA; Cirz RT; Romesberg FE
    J Am Chem Soc; 2007 Dec; 129(51):15830-8. PubMed ID: 18052061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallographic analysis of bacterial signal peptidase in ternary complex with arylomycin A2 and a beta-sultam inhibitor.
    Luo C; Roussel P; Dreier J; Page MG; Paetzel M
    Biochemistry; 2009 Sep; 48(38):8976-84. PubMed ID: 19655811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramolecular Suzuki-Miyaura reaction for the total synthesis of signal peptidase inhibitors, arylomycins A(2) and B(2).
    Dufour J; Neuville L; Zhu J
    Chemistry; 2010 Sep; 16(34):10523-34. PubMed ID: 20658499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci.
    Smith PA; Powers ME; Roberts TC; Romesberg FE
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1130-4. PubMed ID: 21189343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.
    Smith PA; Roberts TC; Romesberg FE
    Chem Biol; 2010 Nov; 17(11):1223-31. PubMed ID: 21095572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological characterization of arylomycin B antibiotics.
    Roberts TC; Smith PA; Romesberg FE
    J Nat Prod; 2011 May; 74(5):956-61. PubMed ID: 21545107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient total synthesis of novel bioactive microbial metabolites.
    Sunazuka T; Hirose T; Omura S
    Acc Chem Res; 2008 Feb; 41(2):302-14. PubMed ID: 18217720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial efforts toward the optimization of arylomycins for antibiotic activity.
    Roberts TC; Schallenberger MA; Liu J; Smith PA; Romesberg FE
    J Med Chem; 2011 Jul; 54(14):4954-63. PubMed ID: 21630667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of the arylomycin lipoglycopeptide antibiotics and the crystallographic analysis of their complex with signal peptidase.
    Liu J; Luo C; Smith PA; Chin JK; Page MG; Paetzel M; Romesberg FE
    J Am Chem Soc; 2011 Nov; 133(44):17869-77. PubMed ID: 21999324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic investigation of the Staphylococcus aureus type I signal peptidase SpsB - implications for the search for novel antibiotics.
    Rao S; Bockstael K; Nath S; Engelborghs Y; Anné J; Geukens N
    FEBS J; 2009 Jun; 276(12):3222-34. PubMed ID: 19438721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier Protein-Free Enzymatic Biaryl Coupling in Arylomycin A2 Assembly and Structure of the Cytochrome P450 AryC.
    Aldemir H; Shu S; Schaefers F; Hong H; Richarz R; Harteis S; Einsiedler M; Milzarek TM; Schneider S; Gulder TAM
    Chemistry; 2022 Jan; 28(2):e202103389. PubMed ID: 34725865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel inhibitors against the bacterial signal peptidase I].
    Liao GJ; He Y; Xie JP
    Yao Xue Xue Bao; 2012 Dec; 47(12):1561-6. PubMed ID: 23460958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual screening.
    Kovac A; Konc J; Vehar B; Bostock JM; Chopra I; Janezic D; Gobec S
    J Med Chem; 2008 Dec; 51(23):7442-8. PubMed ID: 19053785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The total synthesis of tubulysin D.
    Peltier HM; McMahon JP; Patterson AW; Ellman JA
    J Am Chem Soc; 2006 Dec; 128(50):16018-9. PubMed ID: 17165738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I signal peptidase and protein secretion in Staphylococcus epidermidis.
    Powers ME; Smith PA; Roberts TC; Fowler BJ; King CC; Trauger SA; Siuzdak G; Romesberg FE
    J Bacteriol; 2011 Jan; 193(2):340-8. PubMed ID: 21075926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological activity of amamistatin B and analogs.
    Fennell KA; Möllmann U; Miller MJ
    J Org Chem; 2008 Feb; 73(3):1018-24. PubMed ID: 18173285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition.
    Smith PA; Romesberg FE
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5054-60. PubMed ID: 22802255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B; Sarkar C; Biswas R; Pandey S
    Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational antimicrobial drugs for bloodstream infections.
    Korbila IP; Falagas ME
    Curr Opin Investig Drugs; 2008 Aug; 9(8):871-8. PubMed ID: 18666035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.